Drug Profile
BAY 737977
Alternative Names: BAY 73-7977Latest Information Update: 22 Mar 2010
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 22 Mar 2006 Phase-I clinical trials in Diabetes mellitus in Germany (unspecified route)